Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02888665
Brief Title: Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

First Submitted : August 30, 2016
First Submitted that Met QC Criteria : August 30, 2016
First Posted : September 5, 2016 (Estimate)

Results First Submitted : March 12, 2021
Results First Submitted that Met QC Criteria : May 3, 2021
Results First Posted : May 26, 2021

Last Update Submitted that Met QC Criteria : May 3, 2021
Last Update Posted : May 26, 2021